三氧化二砷聯(lián)合衣霉素誘導(dǎo)人乳腺癌MDA-MB-231細胞凋亡作用研究
[Abstract]:Objective: To investigate the effect and mechanism of arsenic trioxide (arsenic trioxide As2O3) combined with ycomycin (Tunicamycin TM) induced MDA-MB-231 apoptosis in human breast cancer cells of three yin. Methods: the normal cell culture of human three yin breast cancer MDA-MB-231 cell lines was used as a model, and the experiments were set up in As2O3 group, TM group and two combination group.As2O3 group and TM group, respectively. The following concentrations [blank control (DMEM) control (DMEM+NaOH/DMSO, 0.1,0.5,1,10,20,40,60,80 mu mol/L)] were respectively established to induce cell 24 h, respectively, and the inhibition rate of cell proliferation was detected by MTT method. According to the inhibitory rate of cell proliferation, 0.5 mu mol/LTM was selected as the fixed concentration, and the combination of different concentration As203 as the combined group of 24h, and then detected by MTT method. Cell proliferation inhibition rate and cell morphological changes under inverted microscope. Cell apoptosis rate and mitochondrial membrane potential change were detected by flow cytometry..Western Blot was used to detect the protein expression and ERS of endoplasmic reticulum stress (endoplasmic reticulum stress ERS) glucose regulator protein 78 (glucose-regulated protein78, GRP78) Apoptosis related protein Caspase4. was selected according to the expression of GRP78 protein, 1 u mol/L As203 combined with 0.5 mol/L TM group, and the cells were pretreated with endoplasmic reticulum stress inhibitor four phenyl butyric acid (Four phenyl butyric acid 4-PBA) for 2 hours. The effect of the drug induced cells after 24 hours was observed. Results: 1, MTT results showed that The 3 groups had both micro proliferation and apoptotic effect on cells. The cell proliferation was promoted by 0.1,0.5,1 mu mol/IL. After 10 mol/L, the cells had inhibitory proliferation and apoptosis effect. Compared with the control group, the cells had statistical significance (P0.05). The TM group had inhibitory effect on the growth of breast cancer cells, and with the increase of drug dosage, the proliferation inhibition rate was clear. The increase was statistically significant (P0.05) compared with the control group (P0.05). The inhibition rate of cell growth was not counteracted under the action of both 0.1,1 mu mol/L and As2O3 combined with TM in the group of 0.1,1 mu mol/L, but the proliferation inhibition rate increased significantly under the interaction of the two groups (P0.0), and there was a significant difference compared with the same concentration of As203 group (P0.0). 5).2, the control cells in group As2O3, TM group and two drug group under light microscope were in good condition, the shape was long spindle shape, and the density was large. With the increase of drug dosage, the growth density of the adherent cells decreased, the cell body crinkled and turned round, the fragments increased obviously, and there were a large number of cells floating.3, As2O3 was 0.1 mu mol/L, 1 mu mol/L, 10 u mol/L, 20 u mol/L, 40 micron mol/L. The apoptosis rate of breast cancer cells was 13.7% + 1.06,16.3% + 1.5,23.5% + 1.5,23.5% + 1.33,50.8% + 1.03 respectively, which was significantly different from that of the control group (P0.05), respectively (P0.05), and the rate of apoptosis was 20.5% + 0.66,22.8% + 0.66,22.8% + 0.95,43.3 + 0.74,51.4% + 0.76, respectively, and 12% + 1.15 with the control group. The significant difference was statistically significant (P0.05).4. The mitochondrial membrane potential of the cells decreased significantly when different concentrations of As2O3 combined with 0.5 u mol/LTM, compared with the control group, with statistical significance (P0.05).5. There was no significant increase in GRP78 expression when As2O3 induced the apoptosis of breast cancer cells, and there was no significant difference compared with the control group. P > 0.05); when TM induced ERS in breast cancer cells, the expression of GRP78 was obviously up-regulated, and the expression of GRP78 in cell ERS was highest with 12 mu mol/L TM, and the difference was statistically significant compared with the control group (P0.05). When the two drugs were combined to induce cells, the highest expression of the 1 mu mol/L As2O3 combined 0.5 micron mol/L was compared with the control group. There was statistically significant (P0.05).6, TM induced the expression of caspase4 in breast cancer cells induced by ERS, and the difference was statistically significant compared with the control group (P0.05). As2O3 combined TM induced breast cancer cells without significant up-regulation or down regulation, and there was no significant difference compared with the control group (P0.05).7. The up - regulation of caspase4 protein expression was blocked for 24 hours, and the difference was statistically significant compared with that of the 4-PBA preconditioning group (P0.05). There was no significant change in the expression of caspase4 protein by As2O3 combined with TM. Compared with the As203 combined TM group, there was no statistical significance (P > 0.05). Conclusion: 1, As2O3 combined TM inducer. The apoptosis rate of MDA-MB-231 cells in breast cancer is better than that of single drug; 2,1 mu mol/L As2O3 combined with 0.5 mu mol/L TM can promote apoptosis of MDA-MB-231 cells, TM can reverse the proliferation promoting effect of As2O3 to inhibit proliferation and promote apoptosis effect. 3, As2O3 combined TM induces apoptosis in human breast cancer MDA-MB-231 cells by two kinds of apoptotic pathways through mitochondria and endoplasmic reticulum stress. Diameter.
【學位授予單位】:貴州醫(yī)科大學
【學位級別】:碩士
【學位授予年份】:2017
【分類號】:R96
【參考文獻】
相關(guān)期刊論文 前10條
1 劉楚羽;謝明均;;三陰乳腺癌臨床靶向治療進展[J];重慶醫(yī)學;2017年02期
2 秦奕男;李丹丹;朱筑霞;;內(nèi)質(zhì)網(wǎng)應(yīng)激誘導(dǎo)人乳腺癌MDA-MB-231細胞系凋亡[J];基礎(chǔ)醫(yī)學與臨床;2016年07期
3 李靜;周偉強;;SAHA、TRAIL與乳腺癌細胞凋亡[J];沈陽醫(yī)學院學報;2016年03期
4 管宇;劉炳彤;臧韻;柳明洙;;珍珠梅黃酮納米粒通過活化內(nèi)質(zhì)網(wǎng)應(yīng)激的Caspase通路抑制大鼠原發(fā)性肝癌的生長[J];時珍國醫(yī)國藥;2015年07期
5 王新;范立君;李壯;王博;周昱;;GRP78、GRP94在乳腺癌中的表達及其意義[J];黑龍江醫(yī)藥科學;2014年06期
6 張維民;楊希才;;三氧化二砷抗腫瘤臨床運用進展[J];中外醫(yī)療;2014年26期
7 李索妮;姚煜;南克俊;;三陰性乳腺癌治療進展[J];現(xiàn)代腫瘤醫(yī)學;2014年01期
8 俞罡;;三氧化二砷治療復(fù)發(fā)性急性早幼粒細胞白血病的療效分析[J];中國醫(yī)藥指南;2013年22期
9 張凱強;張穎;顧何鋒;劉璐;馬林;;內(nèi)質(zhì)網(wǎng)應(yīng)激與細胞凋亡研究進展[J];口腔醫(yī)學;2013年06期
10 王靜霞;張秋榮;;三氧化二砷聯(lián)合沙利度胺對骨髓增生異常綜合征的調(diào)節(jié)作用[J];實用臨床醫(yī)藥雜志;2013年11期
相關(guān)博士學位論文 前1條
1 潘春;Bmbuffy基因在家蠶細胞內(nèi)源性線粒體凋亡途徑與細胞自噬中的功能研究[D];西南大學;2014年
相關(guān)碩士學位論文 前1條
1 胡磊;三氧化二砷對三陰性乳腺癌細胞(MDA-MB-231)的化療增敏作用[D];復(fù)旦大學;2012年
,本文編號:2172817
本文鏈接:http://sikaile.net/yixuelunwen/yiyaoxuelunwen/2172817.html